• Explore /
  • Poster
  • / BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors.

BOLD-100-001 (TRIO039): A phase Ib dose-escalation study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastrointestinal solid tumors.

Abstract Poster

Authors

Grainne M. O'Kane

Grainne M. O'Kane

Princess Margaret Cancer Centre, Toronto, ON, Canada

Grainne M. O'Kane , Jennifer L. Spratlin , Petr Kavan , Rachel Anne Goodwin , Elaine McWhirter , Darby Thompson , Michelle Jones , Edward Russell McAllister , Andres Machado , Yasmin Lemmerick , Leticia Wilson , Jim Pankovich

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04421820

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr TPS145)

DOI

10.1200/JCO.2021.39.3_suppl.TPS145

Abstract #

TPS145

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Jennifer L. Spratlin

First Author: Grainne M. O'Kane

First Author: Yufei Liu

First Author: Scott Kopetz